BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12142612)

  • 1. Histopathology of skin lesions with warty appearance in renal allograft recipients.
    Iraji F; Kiani A; Shahidi S; Vahabi R
    Am J Dermatopathol; 2002 Aug; 24(4):324-5. PubMed ID: 12142612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin disease in immunosuppressed patients in relation to epidermal Langerhans' cells.
    Bergfelt L; Larkö O; Blohmé I
    Acta Derm Venereol; 1993 Oct; 73(5):330-4. PubMed ID: 7904395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated epidermolytic acanthoma with disseminated superficial porokeratosis and verruca vulgaris in an immunosuppressed patient.
    Chun SI; Lee JS; Kim NS; Park KD
    J Dermatol; 1995 Sep; 22(9):690-2. PubMed ID: 8537558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of immunosuppression-related skin disease in long-term transplant patients.
    McLelland J; Rees A; Williams G; Chu T
    Transplantation; 1988 Dec; 46(6):871-4. PubMed ID: 3061083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human papillomavirus 3 in warts of a renal allograft patient.
    Pfister H; Gross G; Hagedorn M
    J Invest Dermatol; 1979 Nov; 73(5):349-53. PubMed ID: 227966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous warts and tumours in immunosuppressed patients.
    Leigh IM; Glover MT
    J R Soc Med; 1995 Feb; 88(2):61-2. PubMed ID: 7769594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin cancer and warts in immunosuppressed renal transplant recipients.
    Leigh IM; Glover MT
    Recent Results Cancer Res; 1995; 139():69-86. PubMed ID: 7597313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion.
    Stark LA; Arends MJ; McLaren KM; Benton EC; Shahidullah H; Hunter JA; Bird CC
    Br J Cancer; 1994 Feb; 69(2):222-9. PubMed ID: 8297718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of immunosuppressants and the risk of warts in renal transplant recipients.
    Dicle O; Parmaksizoglu B; Gurkan A; Tuncer M; Demirbas A; Yilmaz E
    Acta Derm Venereol; 2008; 88(3):294-5. PubMed ID: 18480941
    [No Abstract]   [Full Text] [Related]  

  • 10. Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients.
    Nguyen L; McClellan RB; Chaudhuri A; Alexander SR; Chen SF; Concepcion W; Grimm P
    Transplantation; 2012 Sep; 94(5):450-5. PubMed ID: 22960763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology of skin lesions in renal allograft recipients--an assessment of viral features and dysplasia.
    Blessing K; McLaren KM; Benton EC; Barr BB; Bunney MH; Smith IW; Beveridge GW
    Histopathology; 1989 Feb; 14(2):129-39. PubMed ID: 2540085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of risk factors for cutaneous warts in renal transplant recipients.
    Barba A; Tessari G; Talamini G; Chieregato GC
    Nephron; 1997; 77(4):422-6. PubMed ID: 9434064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifying cyclosporine associated renal allograft dysfunction.
    Mohapatra N; Vanikar AV; Patel RD; Trivedi HL
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):770-4. PubMed ID: 19736471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warts in a pediatric renal transplant population.
    Ingelfinger JR; Grupe WE; Topor M; Levey RH
    Dermatologica; 1977; 155(1):7-12. PubMed ID: 334587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients.
    Spencer ES; Andersen HK
    Br Med J; 1970 Aug; 3(5717):251-4. PubMed ID: 4317670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional injection of bleomycin sulphate into resistant warts in renal transplant recipients versus non-transplant warty patients.
    Sobh MA; Abd El-Razic MM; Rizc RA; Eid MM; Abd el-Hamid IA; Ghoneim MA
    Acta Derm Venereol; 1991; 71(1):63-6. PubMed ID: 1711753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cells, inflammation markers and human papillomavirus infections in benign and malignant epithelial tumors from transplant recipients.
    Viac J; Chardonnet Y; Euvrard S; Chignol MC; Thivolet J
    J Dermatol; 1992 Feb; 19(2):67-77. PubMed ID: 1352312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients.
    Euvrard S; Chardonnet Y; Pouteil-Noble C; Kanitakis J; Chignol MC; Thivolet J; Touraine JL
    Cancer; 1993 Oct; 72(7):2198-206. PubMed ID: 8397062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols.
    Gupta KL; Ghosh AK; Kochhar R; Jha V; Chakrabarti A; Sakhuja V
    Am J Gastroenterol; 1994 Jul; 89(7):1062-5. PubMed ID: 8017366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of dermatological lesions in renal allograft recipients in a tropical environment.
    Chugh KS; Sharma SC; Singh V; Sakhuja V; Jha V; Gupta KL
    Dermatology; 1994; 188(2):108-12. PubMed ID: 8136535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.